SMAC mimetics are potent latency reversal agents with single agent and combination activity ex vivo

• R.M. Dunham,
• G.C. Sampey,
• D.M. Irlbeck,
• E.P. Browne,
• D.M. Margolis

Affiliations

R.M. Dunham

UNC HIV Cure Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA; GlaxoSmithKline, HIV DPU, ID TAU, Research Triangle Park, NC, USA

G.C. Sampey

UNC HIV Cure Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA

D.M. Irlbeck

UNC HIV Cure Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA; GlaxoSmithKline, HIV DPU, ID TAU, Research Triangle Park, NC, USA

E.P. Browne

UNC HIV Cure Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA

D.M. Margolis

UNC HIV Cure Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA